These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2505472)

  • 1. Bone marrow stromal cells in myeloproliferative disorders.
    Hirata J; Takahira H; Kaneko S; Nishimura J; Nawata H
    Acta Haematol; 1989; 82(1):35-9. PubMed ID: 2505472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
    Bartl R; Frisch B; Wilmanns W
    Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased fibroblast colony stimulating activity (F-CSA) in serum of myeloproliferative disorders.
    Han ZC; Briere J; Parent D; Abgrall JF; Sensebe L
    J Biol Regul Homeost Agents; 1988; 2(3):119-24. PubMed ID: 3267102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: only polycythemia vera has endogenous colonies.
    Weinberg RS; Worsley A; Gilbert HS; Cuttner J; Berk PD; Alter BP
    Leuk Res; 1989; 13(4):331-8. PubMed ID: 2716348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
    Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
    Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF.
    Li Y; Hetet G; Maurer AM; Chait Y; Dhermy D; Briere J
    Br J Haematol; 1994 Jul; 87(3):471-6. PubMed ID: 7993786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The colony forming cell in the myeloproliferative disorders and aplastic anaemia.
    Rickard KA; Brown RD; Wilkinson T; Kronenberg H
    Scand J Haematol; 1979 Feb; 22(2):121-8. PubMed ID: 285455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].
    Takahashi M; Fujiwara M
    Rinsho Ketsueki; 1988 Jul; 29(7):994-1000. PubMed ID: 3184486
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic myeloproliferative disorders. The new WHO classification].
    Thiele J; Kvasnicka HM
    Pathologe; 2001 Nov; 22(6):429-43. PubMed ID: 11766643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
    Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E
    Cancer Res; 1986 Feb; 46(2):975-80. PubMed ID: 3455679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous erythroid and megakaryocytic colony formation in serum-free, cytokine-free collagen gels.
    Dobo I; Pineau D; Zandecki M; Hunault M; Hermouet S
    J Hematother Stem Cell Res; 1999 Dec; 8(6):601-7. PubMed ID: 10645767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-hematological characteristics of acute transformation of chronic myeloproliferative syndromes].
    Hernández JM; San Miguel JF; González M; Moraleda JM; Moro MJ; Hernández J; Cuesta B; López Borrasca A
    Med Clin (Barc); 1991 Sep; 97(10):369-72. PubMed ID: 1745085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of interferon in the treatment of chronic myeloproliferative disorders].
    Robak T
    Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity.
    Lundberg LG; Lerner R; Sundelin P; Rogers R; Folkman J; Palmblad J
    Am J Pathol; 2000 Jul; 157(1):15-9. PubMed ID: 10880370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megakaryocytopoiesis in polycythemia vera: characterization by megakaryocytic progenitors (CFU-Meg) in vitro and quantitation of marrow megakaryocytes.
    Kimura H; Ohkoshi T; Matsuda S; Uchida T; Kariyone S
    Acta Haematol; 1988; 79(1):1-6. PubMed ID: 3124455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.